These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2825746)

  • 1. The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease.
    Neale MG; Brown K; Foulds RA; Lal S; Morris DA; Thomas D
    Br J Clin Pharmacol; 1987 Oct; 24(4):493-501. PubMed ID: 2825746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion.
    Aswania OA; Corlett SA; Chrystyn H
    Eur J Clin Pharmacol; 1998 Aug; 54(6):475-8. PubMed ID: 9776438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease.
    Gonzalez JP; Brogden RN
    Drugs; 1987 Nov; 34(5):560-77. PubMed ID: 2826101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease.
    Crimi E; Orefice U; De Benedetto F; Grassi V; Brusasco V
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):501-8. PubMed ID: 7788518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of physiological manoeuvres on the absorption of inhaled nedocromil sodium.
    Ghosh SK; Neale MG; Patel KR
    Br J Clin Pharmacol; 1994 Mar; 37(3):305-8. PubMed ID: 8198943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation.
    Summers QA; Singh S; Honeywell RG; Renwick AG; Holgate ST
    Br J Clin Pharmacol; 1992 Apr; 33(4):431-8. PubMed ID: 1315564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalence of pharmacokinetic characteristics and bronchodilating effect between two combined formulations of nedocromil sodium and salbutamol: MDI and nebulizer solution.
    Reggio S; Bustacchini S; Pistelli R; Valente S
    Int J Clin Pharmacol Res; 1996; 16(1):19-27. PubMed ID: 9001926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report.
    van As A; Chick TW; Bodman SF; Storms WW; Nathan RA; Selner JC; Koepke JW; Townley RG; Bewtra AK; Nair N
    Eur J Respir Dis Suppl; 1986; 147():143-8. PubMed ID: 3021488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration.
    Ensing K; de Zeeuw RA; Nossent GD; Koëter GH; Cornelissen PJ
    Eur J Clin Pharmacol; 1989; 36(2):189-94. PubMed ID: 2524387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):98-107. PubMed ID: 6341263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
    Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
    Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nedocromil sodium: a new therapeutic option for reversible obstructive airways disease.
    Orr TS
    Br J Clin Pract Suppl; 1987 Nov; 53():9-12. PubMed ID: 2849475
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary disease.
    de Jong JW; Postma DS; van der Mark TW; Koëter GH
    Thorax; 1994 Oct; 49(10):1022-4. PubMed ID: 7974297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of beta 2-agonists (in the light of fenoterol).
    Schmidt EW; Ulmer WT; Rominger KL
    Respiration; 1995; 62(4):190-200. PubMed ID: 8578014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.
    Cass LM; Efthymiopoulos C; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade).
    Auty RM
    Eur J Respir Dis Suppl; 1986; 147():120-31. PubMed ID: 3021486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nedocromil sodium therapy in asthma patients. Therapeutic effect in addition to treatment with oral theophylline and inhaled bronchodilator agents].
    Boos R; van Kampen C; Weede W; Beck W
    Fortschr Med; 1989 Nov; 107(33):712-6. PubMed ID: 2557274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.